p22/PRG1: a novel early response gene in pancreatic cancer cells regulated by p53 and NF kappa B.
Schmidt
W E
WE
Department of Medicine, Christian-Albrechts-University of Kiel, Germany. wolfgang.e.schmidt@ruhr-uni-bochum.de
Arlt
A
A
Trauzold
A
A
Schäfer
H
H
D051017:Apoptosis Regulatory Proteins; D001665:Binding Sites; D015500:Chloramphenicol O-Acetyltransferase / Q000235:genetics; D003001:Cloning, Molecular; D015972:Gene Expression Regulation, Neoplastic; D017930:Genes, Reporter; D006367:HeLa Cells; D006801:Humans; D017874:Immediate-Early Proteins / Q000235:genetics*; D008565:Membrane Proteins; D016328:NF-kappa B / Q000378:metabolism*; D009363:Neoplasm Proteins; D010190:Pancreatic Neoplasms / Q000235:genetics*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism / Q000494:pharmacology; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism*
D051017:Apoptosis Regulatory Proteins; C099815:IER3 protein, human; D017874:Immediate-Early Proteins; D008565:Membrane Proteins; D016328:NF-kappa B; D009363:Neoplasm Proteins; D014409:Tumor Necrosis Factor-alpha; D016159:Tumor Suppressor Protein p53; D015500:Chloramphenicol O-Acetyltransferase